引用本文
  •    [点击复制]
  •    [点击复制]
PDF HTML全文阅读
本文已被:浏览 445次   下载 286 本文二维码信息
码上扫一扫!
补虚健脾通络方对直肠前切除综合征患者的疗效及炎症细胞因子的影响
崔娟娟,葛小栋,陈树山,张璇,郑娜
唐山市中医医院肛肠科唐山 063000
摘要:
目的:探究补虚健脾通络方对直肠前切除综合征(ARS)患者的疗效以及对炎症细胞因子的影响。方法:选取2020年1月—2023年4月我院收治的脾气亏虚型ARS患者116例,采用随机数字表法分为对照组及观察组,每组各58例。对照组进行基础康复训练,观察组在对照组的基础上同时采用补虚健脾通络方进行治疗。评估并比较治疗前、治疗4周后两组患者的中医证候积分,评估临床疗效,检测两组患者治疗前后炎症细胞因子水平[肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)、C反应蛋白(CRP)]及排便相关指标(排便次数及大便失禁频次评分),采用生活质量量表(QLQ-C30)评分评估两组患者治疗前后的生活质量。结果:观察组治疗总有效率为91.38%,高于对照组的75.86%(P <0.05);两组患者治疗后主症、次症及总积分均降低,且观察组各项积分均低于对照组(P <0.05);两组患者治疗后TNF-ɑ、IL-6及CRP水平均降低,且观察组各指标水平更低(P <0.05);两组患者治疗后排便次数、大便失禁频次评分均降低(P <0.05),且观察组低于对照组(P <0.05);两组患者治疗后QLQ-C30评分均升高,且观察组QLQ-C30评分高于对照组(P <0.05)。结论:补虚健脾通络方能够改善ARS患者的临床症状,提高疗效,改善机体炎症水平及排便情况,提高患者生活质量,且安全性较高。
关键词:  直肠前切除综合征  补虚健脾通络方  炎症细胞因子  脾气亏虚证
DOI:10.3969/j.issn.1007-6948.2025.03.002
投稿时间:2024-07-05
基金项目:河北省中医药管理局科研计划项目(2024155)
Effect of tonifying deficiency and invigorating spleen Tongluo formula on anterior rectal resection syndrome and influence of inflammatory cytokines
CUI Juan-juan,GE Xiao-dong,CHEN Shu-shan
Department of Anorectal, Tangshan Traditional Chinese Medicine Hospital, Tangshan063000, China
Abstract:
Objective To explore the effect of tonifying deficiency and invigorating spleen Tongluo formula on anterior rectal resection syndrome (ARS) and the effect on inflammatory cytokines. Methods A total of 116 ARS patients with temper deficiency from January 2020 to April 2023 were selected. The patients were divided into two groups with 58 cases each by random number table method. The control group received basic rehabilitation training, and the observation group received basic rehabilitation training and was treated with tonifying deficiency and invigorating spleen Tongluo formula. The TCM syndrome scores of the patients were evaluated before treatment and 4 weeks after treatment, and the clinical efficacy was evaluated. The levels of inflammatory cytokines[tumor necrosis factor-α (TNF-α, interleukin-6 (IL-6) and C-reactive protein (CRP)] and defecation-related indicators (score of defecation frequency and fecal incontinence frequency) of the patients were detected before and after treatment. QLQ-C30 score was used to evaluate the quality of life of patients before and after treatment. Results The total effective rate of ARS patients in observation group was 91.38%, which was higher than that in control group (75.86%, P <0.05). The main, secondary and total scores of ARS patients in two groups were decreased after treatment, and the scores in observation group were lower than those in control group (P <0.05). The levels of TNF-alpha, IL-6 and CRP in ARS patients in the two groups were all reduced after treatment, and the levels in the observation group were lower (P<0.05). The frequency of defecation and the frequency of fecal incontinence were decreased in both groups after treatment(P <0.05), and the frequency of defecation and frequency of fecal incontinence in the observation group were lower than those in the control group (P <0.05). The QLQ-C30 score of ARS patients in both groups was higher after treatment, and that in the observation group was higher (P <0.05). Conclusion Tonifying deficiency and invigorating spleen Tongluo formula can improve the clinical symptoms of patients with ARS rectum, improve the therapeutic effect, improve the level of inflammation and defecation, and improve the quality of life of patients with high safety.
Key words:  Anterior rectal resection syndrome  tonifying deficiency and invigorating spleen Tongluo formula  inflammatory cytokines  Qi deficiency syndrome

用微信扫一扫

用微信扫一扫